{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:59:47Z","timestamp":1785301187121,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.tice.2025.103221","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T15:50:28Z","timestamp":1762617028000},"page":"103221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["WTAP-mediated m6A modification of PRMT1 regulates cuproptosis to promote anaplastic thyroid carcinoma progression"],"prefix":"10.1016","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2248-3798","authenticated-orcid":false,"given":"Guoli","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changju","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taolang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.tice.2025.103221_bib1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3892\/mco.2023.2695","article-title":"Anaplastic thyroid cancer: pathogenesis, prognostic factors and genetic landscape (Review)","volume":"19","author":"Alhejaily","year":"2023","journal-title":"Mol. Clin. Oncol."},{"key":"10.1016\/j.tice.2025.103221_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1369780","article-title":"Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapy","volume":"15","author":"Turner","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tice.2025.103221_bib3","article-title":"Immunotherapy or targeted therapy: What will be the future treatment for anaplastic thyroid carcinoma?","volume":"13","author":"Gao","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.tice.2025.103221_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122110","article-title":"Advances and challenges in thyroid cancer: the interplay of genetic modulators, targeted therapies, and AI-driven approaches","volume":"332","author":"Bhattacharya","year":"2023","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.tice.2025.103221_bib5","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1139\/bcb-2023-0212","article-title":"Protein arginine methyltransferase 1, a major regulator of biological processes","volume":"102","author":"Sudhakar","year":"2024","journal-title":"Biochem. Cell Biol."},{"issue":"5","key":"10.1016\/j.tice.2025.103221_bib6","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/s12276-021-00613-y","article-title":"Protein arginine methyltransferases: promising targets for cancer therapy","volume":"53","author":"Hwang","year":"2021","journal-title":"Exp. Mol. Med."},{"issue":"11","key":"10.1016\/j.tice.2025.103221_bib7","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3390\/life11111147","article-title":"Structure, activity, and function of PRMT1","volume":"11","author":"Thiebaut","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.tice.2025.103221_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1420365","article-title":"Dysregulation of arginine methylation in tumorigenesis","volume":"11","author":"Li","year":"2024","journal-title":"Front. Mol. Biosci."},{"issue":"5","key":"10.1016\/j.tice.2025.103221_bib9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41419-019-1595-0","article-title":"PRMT1 regulates the tumour-initiating properties of esophageal squamous cell carcinoma through histone H4 arginine methylation coupled with transcriptional activation","volume":"10","author":"Zhao","year":"2019","journal-title":"Cell Death Dis."},{"issue":"16","key":"10.1016\/j.tice.2025.103221_bib10","doi-asserted-by":"crossref","first-page":"8854","DOI":"10.3390\/ijms25168854","article-title":"Role of PRMT1 and PRMT5 in breast cancer","volume":"25","author":"Martinez","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"21","key":"10.1016\/j.tice.2025.103221_bib11","doi-asserted-by":"crossref","first-page":"13479","DOI":"10.1074\/jbc.M114.636050","article-title":"PRMT1 is a novel regulator of epithelial-mesenchymal-transition in non-small cell lung cancer","volume":"290","author":"Avasarala","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.tice.2025.103221_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114176","article-title":"PRMT1 promotes epigenetic reprogramming associated with acquired chemoresistance in pancreatic cancer","volume":"43","author":"Nguyen","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.tice.2025.103221_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115327","article-title":"DB75 targets PRMT1 to suppress liver metastasis and synergizes with PD-L1 blockade for enhanced therapeutic efficacy","volume":"164","author":"Sun","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.tice.2025.103221_bib14","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1016\/j.gendis.2023.02.006","article-title":"PRMT1 promotes the proliferation and metastasis of gastric cancer cells by recruiting MLXIP for the transcriptional activation of the \u03b2-catenin pathway","volume":"10","author":"Wang","year":"2023","journal-title":"Genes Dis."},{"issue":"1","key":"10.1016\/j.tice.2025.103221_bib15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","article-title":"The role of m6A modification in the biological functions and diseases","volume":"6","author":"Jiang","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.tice.2025.103221_bib16","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1038\/s41467-021-24035-6","article-title":"Arginine methylation of METTL14 promotes RNA N6-methyladenosine modification and endoderm differentiation of mouse embryonic stem cells","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tice.2025.103221_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2023.100912","article-title":"PRMT1 methylates METTL14 to modulate its oncogenic function","volume":"42","author":"Wang","year":"2023","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.tice.2025.103221_bib18","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","article-title":"Copper homeostasis and cuproptosis in health and disease","volume":"7","author":"Chen","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.tice.2025.103221_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s11658-024-00608-3","article-title":"Cuproptosis in cancer: biological implications and therapeutic opportunities","volume":"29","author":"Li","year":"2024","journal-title":"Cell Mol. Biol. Lett."},{"issue":"1","key":"10.1016\/j.tice.2025.103221_bib20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s12964-024-01625-7","article-title":"Cuproptosis: unveiling a new frontier in cancer biology and therapeutics","volume":"22","author":"Feng","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.tice.2025.103221_bib21","article-title":"Targeting cuproptosis for cancer therapy: Focus on the anti-tumor immune system","author":"Zhang","year":"2024","journal-title":"Cancer Pathog. Ther."},{"issue":"1","key":"10.1016\/j.tice.2025.103221_bib22","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1038\/s41467-023-42025-8","article-title":"Lactylation of METTL16 promotes cuproptosis via m6A-modification on FDX1 mRNA in gastric cancer","volume":"14","author":"Sun","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tice.2025.103221_bib23","article-title":"Prognosis and immune infiltration analysis of m6A RNA methylation regulators in cutaneous melanoma and differential analysis with cuproptosis related genes","author":"C-c","year":"2024","journal-title":"Int. J. Dermatol. Venereol."},{"issue":"40","key":"10.1016\/j.tice.2025.103221_bib24","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1038\/s41388-024-03139-5","article-title":"m6A modification of lipoyltransferase 1 inhibits bladder cancer progression by activating cuproptosis","volume":"43","author":"Du","year":"2024","journal-title":"Oncogene"},{"issue":"17","key":"10.1016\/j.tice.2025.103221_bib25","doi-asserted-by":"crossref","first-page":"9780","DOI":"10.3390\/ijms23179780","article-title":"The role of protein arginine methyltransferases in DNA damage response","volume":"23","author":"Brobbey","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tice.2025.103221_bib26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/JHC.S443130","article-title":"PRMT1 integrates immune microenvironment and fatty acid metabolism response in progression of hepatocellular carcinoma","volume":"11","author":"Yan","year":"2024","journal-title":"J. Hepatocell. Carcinoma"},{"issue":"3","key":"10.1016\/j.tice.2025.103221_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.113831","article-title":"PRMT1 acts as a suppressor of MHC-I and anti-tumor immunity","volume":"43","author":"Djajawi","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.tice.2025.103221_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2024.110040","article-title":"PRMT1 mediates the proliferation of Y79 retinoblastoma cells by regulating the p53\/p21\/CDC2\/cyclin B pathway","volume":"247","author":"Zhang","year":"2024","journal-title":"Exp. Eye Res."},{"issue":"8","key":"10.1016\/j.tice.2025.103221_bib29","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41419-023-06036-z","article-title":"PRMT1 methylation of WTAP promotes multiple myeloma tumorigenesis by activating oxidative phosphorylation via m6A modification of NDUFS6","volume":"14","author":"Jia","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.tice.2025.103221_bib30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12094-022-02940-6","article-title":"Characterization of m6A methylation modifications and tumor microenvironment infiltration in thyroid cancer","volume":"25","author":"Ji","year":"2023","journal-title":"Clin. Transl. Oncol."},{"issue":"19","key":"10.1016\/j.tice.2025.103221_bib31","doi-asserted-by":"crossref","first-page":"11516","DOI":"10.3390\/ijms231911516","article-title":"Role of m6A RNA methylation in thyroid cancer cell lines","volume":"23","author":"Allegri","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.tice.2025.103221_bib32","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41419-024-07097-4","article-title":"FTO\/IGF2BP2-mediated N6 methyladenosine modification in invasion and metastasis of thyroid carcinoma via CDH12","volume":"15","author":"Chen","year":"2024","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.tice.2025.103221_bib33","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13062-024-00566-y","article-title":"YTHDF2 promotes anaplastic thyroid cancer progression by activating the DDIT4\/AKT\/mTOR signaling pathway","volume":"19","author":"Dai","year":"2024","journal-title":"Biol. Direct"},{"issue":"9","key":"10.1016\/j.tice.2025.103221_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/cns.70039","article-title":"Cuproptosis: mechanisms, biological significance, and advances in disease treatment\u2014a systematic review","volume":"30","author":"Pan","year":"2024","journal-title":"CNS Neurosci. Ther."}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816625005038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816625005038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:11:50Z","timestamp":1785298310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816625005038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":34,"alternative-id":["S0040816625005038"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2025.103221","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"WTAP-mediated m6A modification of PRMT1 regulates cuproptosis to promote anaplastic thyroid carcinoma progression","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2025.103221","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103221"}}